bioRxivImmunology
Early cellular mechanism of type I interferon-driven susceptibility to tuberculosis
D. I. Kotov, O. V. Lee, S. A. Fattinger, C. Langner, J. V. Guillen, J. M. Peters, A. Moon, E. M. Burd, K. C. Witt, D. B. Stetson, D. L. Jaye, B. D. Bryson, R. E. Vance
Abstract
Mycobacterium tuberculosis (Mtb) causes 1.6 million deaths annually. Active tuberculosis correlates with a neutrophil-driven type I interferon (IFN) signature, but the cellular mechanisms underlying tuberculosis pathogenesis remain poorly understood. We found interstitial macrophages (IMs) and plasmacytoid dendritic cells (pDCs) are dominant producers of type I IFN during Mtb infection in mice and non-human primates, and pDCs localize near human Mtb granulomas. Depletion of pDCs reduces Mtb burdens, implicating pDCs in tuberculosis pathogenesis. During IFN-driven disease, we observe abundant DNA-containing neutrophil extracellular traps (NETs) known to activate pDCs. Cell type-specific disruption of the type I IFN receptor suggests IFNs act on IMs to inhibit Mtb control. Single cell RNA-seq indicates type I IFN-responsive cells are defective in their response to IFN{gamma}, a cytokine critical for Mtb control. We propose pDC-derived type I IFNs act on IMs to drive bacterial replication, further neutrophil recruitment, and active tuberculosis disease.
- organism: mouse
- organism: non-human primate
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type I IFN signaling mediates NET release to promote Mycobacterium tuberculosis replication and granuloma caseation
C. Sur Chowdhury, R. L. Kinsella, … C. L. Stallings·bioRxiv·Nov 29, 2022
- Neutrophils reprograms the bone marrow to impair T-cell immunity during tuberculosis
M. Saqib, E. McDonough, … B. B. Mishra·bioRxiv·Jun 28, 2022
- Type I interferon-driven lung pathology restricts T cell accumulation and motility during tuberculosis
Maxime Caouaille, Léa Fromont, … Denis Hudrisier·bioRxiv·Jun 3, 2026
- Strong sustained type I IFN signaling acts cell intrinsically to impair IFNγ responses and cause tuberculosis susceptibility
Stefan A. Fattinger, Parisi Bianca, … Russell E. Vance·Cell Host & MicrobePeer-reviewed·Aug 14, 2026
- Re-appraising the role of T-cell derived interferon gamma in restriction of Mycobacterium tuberculosis in the murine lung
Karolina Maciag, Courtney Ray Plumlee, … Kevin B. Urdahl·The Journal of ImmunologyPeer-reviewed·Jun 24, 2024
- Human macrophages secrete both interferon α and interferon β protein during infection with Mycobacterium tuberculosis.
Gina R. Leisching, Donal J Cox, … Joseph Keane·Journal of Interferon & Cytokine ResearchPeer-reviewed·Apr 27, 2026